Literature DB >> 20433992

The National Comprehensive Cancer Center Network (NCCN) guidelines on the management of venous thromboembolism in cancer patients.

Michael B Streiff1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20433992     DOI： 10.1016/S0049-3848(10)70030-X

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  16 in total

1.  Safety of postoperative thromboprophylaxis after major hepatobiliary-pancreatic surgery in Japanese patients.

Authors:  Hiroki Hayashi; Takanori Morikawa; Hiroshi Yoshida; Fuyuhiko Motoi; Takaho Okada; Kei Nakagawa; Masamichi Mizuma; Takeshi Naitoh; Yu Katayose; Michiaki Unno
Journal:  Surg Today       Date:  2014-04-01       Impact factor: 2.549

Review 2.  Deep Vein Thrombosis Interventions in Cancer Patients.

Authors:  Resmi Ann Charalel; Suresh Vedantham
Journal:  Semin Intervent Radiol       Date:  2017-03       Impact factor: 1.513

3.  Investigating the benefit of adding a vena cava filter to anticoagulation with fondaparinux sodium in patients with cancer and venous thromboembolism in a prospective randomized clinical trial.

Authors:  Myra F Barginear; Richard J Gralla; Thomas P Bradley; Syed S Ali; Iuliana Shapira; Craig Greben; Nanette Nier-Shoulson; Meredith Akerman; Martin Lesser; Daniel R Budman
Journal:  Support Care Cancer       Date:  2012-03-16       Impact factor: 3.603

4.  Incidence of Venous Thromboembolism by Type of Gynecologic Malignancy and Surgical Modality in the National Surgical Quality Improvement Program.

Authors:  Ashley Graul; Nawar Latif; Xiaochen Zhang; Lorraine T Dean; Mark Morgan; Robert Giuntoli; Robert Burger; Sarah Kim; Emily Ko
Journal:  Int J Gynecol Cancer       Date:  2017-03       Impact factor: 3.437

5.  Thromboprophylaxis for lung cancer patients--multimodality assessment of clinician practices, perceptions and decision support tools.

Authors:  M Alexander; S Kirsa; M MacManus; D Ball; B Solomon; K Burbury
Journal:  Support Care Cancer       Date:  2014-02-27       Impact factor: 3.603

Review 6.  Anticoagulation in the management of venous thromboembolism in the cancer patient.

Authors:  Michael B Streiff
Journal:  J Thromb Thrombolysis       Date:  2011-04       Impact factor: 2.300

7.  Predictors of Interventional Treatment Use for Venous Thromboembolism in Cancer Patients.

Authors:  Lara Yoon; Grace Clarke Hillyer; Ling Chen; Jim C Hu; Alfred I Neugut; Dawn L Hershman; Jason D Wright
Journal:  Cancer Invest       Date:  2016-09-13       Impact factor: 2.176

8.  Patients treated for acute VTE during periods of treatment-related thrombocytopenia have high rates of recurrent thrombosis and transfusion-related adverse outcomes.

Authors:  B T Samuelson Bannow; R B Walter; T B Gernsheimer; D A Garcia
Journal:  J Thromb Thrombolysis       Date:  2017-11       Impact factor: 2.300

9.  Comparative assessment of low-molecular-weight heparins in cancer from the perspective of patient outcomes and survival.

Authors:  Anna Falanga; Alfonso Vignoli; Erika Diani; Marina Marchetti
Journal:  Patient Relat Outcome Meas       Date:  2011-11-23

Review 10.  Venous Thromboembolism in Cancer: An Update of Treatment and Prevention in the Era of Newer Anticoagulants.

Authors:  Waqas Qureshi; Zeeshan Ali; Waseem Amjad; Zaid Alirhayim; Hina Farooq; Shayan Qadir; Fatima Khalid; Mouaz H Al-Mallah
Journal:  Front Cardiovasc Med       Date:  2016-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.